Cargando…

MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients

BACKGROUND: In recent years, microRNA (miRNA) pathways have emerged as a crucial system for the regulation of tumorogenesis. miR-SNPs are a novel class of single nucleotide polymorphisms that can affect miRNA pathways. DESIGN AND METHODS: We analyzed eight miR-SNPs by allelic discrimination in 141 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Alfons, Muñoz, Carmen, Gaya, Anna, Díaz-Beyá, Marina, Gel, Bernat, Tejero, Rut, Díaz, Tania, Martinez, Antonio, Monzó, Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660374/ https://www.ncbi.nlm.nih.gov/pubmed/23705004 http://dx.doi.org/10.1371/journal.pone.0064716

Ejemplares similares

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis
por: Diaz, Tania, et al.
Publicado: (2011)

PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2016)

Non-Coding RNAs in Hodgkin Lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2017)

A Dual Role for KRT81: A miR-SNP Associated with Recurrence in Non-Small-Cell Lung Cancer and a Novel Marker of Squamous Cell Lung Carcinoma
por: Campayo, Marc, et al.
Publicado: (2011)

Differential MIR-21 Expression in Plasma From Mesenteric Versus Peripheral Veins: An Observational Study of Disease-free Survival in Surgically Resected Colon Cancer Patients
por: Monzo, Mariano, et al.
Publicado: (2015)

miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma
por: Tejero, Rut, et al.
Publicado: (2014)

A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma
por: Navarro, Alfons, et al.
Publicado: (2015)

SNPs Array Karyotyping in Non-Hodgkin Lymphoma
por: Etebari, Maryam, et al.
Publicado: (2015)

The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer
por: Navarro, Alfons, et al.
Publicado: (2015)

Clinic and therapeutic potential of non-coding RNAs in cancer
por: Castellano, Joan Josep, et al.
Publicado: (2021)

MicroRNAs in Human Embryonic and Cancer Stem Cells
por: Navarro, Alfons, et al.
Publicado: (2010)

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
por: Campayo, Marc, et al.
Publicado: (2018)

LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients
por: Li, Yan, et al.
Publicado: (2020)

Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
por: Benitez, Jose Carlos, et al.
Publicado: (2021)

Frequency of Autoantibodies on Non-Hodgkin Lymphoma
por: Barreno-Rocha, Sonia Guadalupe, et al.
Publicado: (2023)

Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma
por: Ansell, Stephen M.
Publicado: (2017)

Bleomycin in Hodgkin's Lymphoma – A Boon or a Bane? – A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma
por: Udupa, Chethana Babu K, et al.
Publicado: (2019)

Digital Ischemia as an Unusual Manifestation of Hodgkin's Lymphoma
por: Villano, Fiorella, et al.
Publicado: (2018)

Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer()
por: Santasusagna, Sandra, et al.
Publicado: (2018)

Pulmonary toxicity induced by bleomycin in a patient with Hodgkin lymphoma
por: Oliveira, CF, et al.
Publicado: (2005)

Efficacies and Toxicities of Seven Chemotherapy Regimens for Advanced Hodgkin Lymphoma
por: Pei, Fajun, et al.
Publicado: (2021)

Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
por: Barrett, Aisling, et al.
Publicado: (2023)

Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines
por: Canals, Jordi, et al.
Publicado: (2022)

Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma
por: Sabet, Yasmin, et al.
Publicado: (2016)

Hodgkin Lymphoma in People Living with HIV
por: Navarro, Jose-Tomas, et al.
Publicado: (2021)

Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer
por: Monzo, Mariano, et al.
Publicado: (2017)

Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer
por: Han, Bing, et al.
Publicado: (2022)

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
por: Toltz, Allison, et al.
Publicado: (2015)

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
por: Pepper, Niklas Benedikt, et al.
Publicado: (2020)

Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
por: Follows, Annabel M., et al.
Publicado: (2022)

YKT6 expression, exosome release, and survival in non-small cell lung cancer
por: Ruiz-Martinez, Marc, et al.
Publicado: (2016)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study
por: Jona, Adam, et al.
Publicado: (2021)

Long-term follow up of Hodgkin lymphoma
por: Perez-Callejo, David, et al.
Publicado: (2018)

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets
por: Mata, Elena, et al.
Publicado: (2017)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hf4rf32pfsjnnfk3dqrau05asm